Patogeneticheskie aspekty ozhireniya
https://doi.org/10.14341/2071-8713-5172
About the Authors
I I DedovEndocrinology Research Centre, Moscow
Russian Federation
G A Mel'nichenko
Endocrinology Research Centre, Moscow
Russian Federation
T I Romantsova
I.M.Sechenov Moscow Medical Academy
Russian Federation
References
1. Балаболкин М. И., Клебанова Г. М. Патогенетическая терапия сахарного диабета типа 2. // Клиническая эндокринология. 2000; 11: 1-6.
2. Altman J. Weight in the balance. // Neuroendocrinology.- 2002; 76: 131-6.
3. Haunter H. Human adipocytes - state of the art. In: Progress in obesity research. 8th International congress on obesity. B. Guy-Grand, G. Ailhaud, eds. London: John Libbey. 1999; 47-53.
4. Hotamasligil G. S. Molecular mechanism of insulin resistance and the role of the adipocyte. // Int J Obes. 2000; 24 (Suppl. 4): 23-7.
5. Neel J. V. Diabetes mellitus: a thrifty genotype rendered detrimental by "progress"? // Am J Hum Genet. 1962; 14:353-62.
6. Rohner-Jeanrenaud F., Jeanrenaud B. Neuroendocrine aspects of obesity: rela- tionships between neuropeptide Y and leptin. // Topical Endocrinol.- 1997; 6: 7-10.
7. Thompson D., Wolf A. What is the economic case for treating obesity? // Obes Res.- 1998; 6 (Suppl.1): 2-7.
8. Wilks R., McFarlane-Anderson N., Bennett F. et al. Obesity in people of the African diaspora. In: The origins and сonsequences of obesity. D. Chadwick, G. Cardew, eds. Chichester: John Wiley & Sons. 1996; 37-48.
Review
For citations:
Dedov I.I., Mel'nichenko G.A., Romantsova T.I. Patogeneticheskie aspekty ozhireniya. Obesity and metabolism. 2004;1(1):3-9. (In Russ.) https://doi.org/10.14341/2071-8713-5172
Views:
803
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
